Rituxan (rituximab) - Roche
Clinical Outcomes and Treatment Efficacy in Juvenile Myasthenia Gravis: A Retrospective Review From a Single Center. (PubMed, Muscle Nerve) - Sep 17, 2026 - "Earlier immunosuppression was associated with a higher remission rate, whereas treatment tended to be initiated later and remission was less frequent in OMG. These findings support a timely treatment approach in JMG." 
Clinical data • Journal • Retrospective data • CNS Disorders • Immunology • Myasthenia Gravis • Pediatrics
http://www.ncbi.nlm.nih.gov/pubmed/42749614
 
Elisa Nigro; Freddy Paiz; Hernan Gonorazky; Tanitnun Paprad; Zahra Aleisa
 
Sep 17, 2026
 
Prev Next